Mier W - Search Results

1

Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF).

Storck P, Umstätter F, Wohlfart S, Domhan C, Kleist C, Werner J, Brandenburg K, Zimmermann S, Haberkorn U, Mier W, Uhl P. Storck P, et al. Among authors: mier w. Antibiotics (Basel). 2020 Nov 26;9(12):844. doi: 10.3390/antibiotics9120844. Antibiotics (Basel). 2020. PMID: 33255900 Free PMC article.

2

Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Bioconjug Chem. 2000 Nov-Dec;11(6):855-60. doi: 10.1021/bc000041k. Bioconjug Chem. 2000. PMID: 11087334

3

Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone.

Haberkorn U, Kinscherf R, Krammer PH, Mier W, Eisenhut M. Haberkorn U, et al. Among authors: mier w. Nucl Med Biol. 2001 Oct;28(7):793-8. doi: 10.1016/s0969-8051(01)00247-5. Nucl Med Biol. 2001. PMID: 11578900

4

Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.

Henze M, Mohammed A, Mier W, Rudat V, Dietz A, Nollert J, Eisenhut M, Haberkorn U. Henze M, et al. Among authors: mier w. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):324-30. doi: 10.1007/s00259-001-0703-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002706 Clinical Trial.

5

Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.

Henze M, Mohammed A, Schlemmer H, Herfarth KK, Mier W, Eisenhut M, Debus J, Haberkorn U. Henze M, et al. Among authors: mier w. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1455-61. doi: 10.1007/s00259-002-0896-0. Epub 2002 Aug 20. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397464 Clinical Trial.

6

Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural element.

Eisenhut M, Mohammed A, Mier W, Schönsiegel F, Friebe M, Mahmood A, Jones AG, Haberkorn U. Eisenhut M, et al. Among authors: mier w. J Med Chem. 2002 Dec 19;45(26):5802-5. doi: 10.1021/jm021026z. J Med Chem. 2002. PMID: 12477363

7

Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Angew Chem Int Ed Engl. 2003 Apr 29;42(17):1968-71. doi: 10.1002/anie.200219978. Angew Chem Int Ed Engl. 2003. PMID: 12730984 No abstract available.

8

2,3,5,6-Tetrafluorophenyl N-(S-benzoylthioacetyl)glycylglycyl- p-aminobenzoate, a heterobifunctional (99m)Tc ligand for precomplexed antibody labeling.

Calderon Sanchez O, Mohammed A, Mier W, Graham K, Schuhmacher J, Arndt SO, Haberkorn U, Mocelo R, Eisenhut M. Calderon Sanchez O, et al. Among authors: mier w. Bioconjug Chem. 2003 Nov-Dec;14(6):1209-13. doi: 10.1021/bc034091b. Bioconjug Chem. 2003. PMID: 14624637

9

Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.

Sieger S, Jiang S, Kleinschmidt J, Eskerski H, Schönsiegel F, Altmann A, Mier W, Haberkorn U. Sieger S, et al. Among authors: mier w. Cancer Gene Ther. 2004 Jan;11(1):41-51. doi: 10.1038/sj.cgt.7700654. Cancer Gene Ther. 2004. PMID: 14681725

10

Impact of functional genomics and proteomics on radionuclide imaging.

Haberkorn U, Altmann A, Mier W, Eisenhut M. Haberkorn U, et al. Among authors: mier w. Semin Nucl Med. 2004 Jan;34(1):4-22. doi: 10.1053/j.semnuclmed.2003.09.003. Semin Nucl Med. 2004. PMID: 14735455 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters